Document type

Article

Version

Published version

Publication date

Publication license

cc-by-nc-sa (c) Germà Lluch, José Ramón et al., 1980
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/120654

Tumour-marker levels and prognosis in malignant teratoma of the testis

Journal Title

Director/Tutor

Journal ISSN

Volume Title

Abstract

The effect of 6 putative prognostic factors on survival was studied in patients with Stages III and IV malignant teratoma of the testis. Differences between survival curves were tested for statistical significance. A diameter greater than 5 cm in the largest tumour mass, and greater than 8 pulmonary metastases were adverse prognostic factors (P = 0.004 and 0.008 respectively). Patients with malignant teratoma, trophoblastic, fared worse than those with malignant teratoma, undifferentiated, and malignant teratoma, intermediate (P = 0.011 and 0.023 respectively). Previous chemotherapy or radiotherapy had no significant effect. Serum alpha-foetoprotein (AFP) above 10(3) MRC u/ml and serum beta subunit of human chorionic gonadotrophin (hCG) above 10(5) miu/ml, were found to predict a poor prognosis (P = 0.010 and 0.001 respectively). A combination of measurements of the tumour markers gave the most consistent indication of prognosis, in that patients with either AFP greater than 10(3) MRC u/ml or hCG greater than 10(5) miu/ml, or both, fared much worse than those with neither factor (P = 0.001). Serum concentrations of AFP and hCG should be stated in reports of treatment of testicular teratoma in order to provide a basis for comparison with other series. Regular and frequent measurements of these markers are appropriate throughout the clinical management of patients with malignant teratoma.

Citation

Citation

GERMÀ LLUCH, José Ramón, BEGENT, R. H. J. and BAGSHAWE, K. D. Tumour-marker levels and prognosis in malignant teratoma of the testis. British Journal of Cancer. 1980. Vol. 42, num. 6, pags. 850-855. ISSN 0007-0920. [consulted: 16 of June of 2026]. Available at: https://hdl.handle.net/2445/120654

Export metadata

JSON - METS

Share record